TORONTO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that its executive management team will participate in the following upcoming conferences in September.
ATB Capital Markets Life Sciences Institutional Investor Conference, September 20, 2023, in New York City: Ziad Ghanem, TerrAscend’s Chief Executive Officer, and Noah Hamman, Founder and CEO of AdvisorShares, will participate in a panel discussion titled “The Quest for Trading Liquidity and Institutional Investors” at 11:15 AM ET. For more information, please contact your ATB representative.
Benzinga Cannabis Capital Conference, September 27-28, 2023, in Chicago: Jason Wild, Executive Chairman, will be the keynote speaker at 9:30 AM CT on Thursday, September 28th. For more information, please click here.
Management including Jason Wild, Ziad Ghanem, and Keith Stauffer, Chief Financial Officer, will be available for one-on-one meetings throughout the day at both conferences. Please reach out to your conference representative or email IR@TerrAscend.com.
About TerrAscend
is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including vertically integrated operations in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. and retail operations in Canada through TerrAscend Canada Inc. (“TerrAscend”). TerrAscend operates The Apothecarium, Gage and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. For more information visit www.terrascend.com.
For more information regarding TerrAscend:
Keith Stauffer
Chief Financial Officer
IR@terrascend.com
855-837-7295
Briana Chester
MATTIO Communications
424-465-4419
terrascend@mattio.com
